MHC Class II Restricted Innate-like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania Major
Overview
Affiliations
Although it is generally believed that CD4(+) T cells play important roles in anti-Leishmania immunity, some studies suggest that they may be dispensable, and that MHC II-restricted CD3(+)CD4(-)CD8(-) (double negative, DN) T cells may be more important in regulating primary anti-Leishmania immunity. In addition, while there are reports of increased numbers of DN T cells in Leishmania-infected patients, dogs and mice, concrete evidence implicating these cells in secondary anti-Leishmania immunity has not yet been documented. Here, we report that DN T cells extensively proliferate and produce effector cytokines (IFN-γ, TNF and IL-17) and granzyme B (GrzB) in the draining lymph nodes and spleens of mice following primary and secondary L. major infections. DN T cells from healed mice display functional characteristics of protective anti-Leishmania memory-like cells: rapid and extensive proliferation and effector cytokines production following L. major challenge in vitro and in vivo. DN T cells express predominantly (> 95%) alpha-beta T cell receptor (αβ TCR), are Leishmania-specific, restricted mostly by MHC class II molecules and display transcriptional profile of innate-like genes. Using in vivo depletion and adoptive transfer studies, we show that DN T cells contribute to optimal primary and secondary anti-Leishmania immunity in mice. These results directly identify DN T cells as important players in effective and protective primary and secondary anti-L. major immunity in experimental cutaneous leishmaniasis.
Lai R, Deng X, Lv X, Zhong Y Sci Rep. 2024; 14(1):30070.
PMID: 39627303 PMC: 11615377. DOI: 10.1038/s41598-024-80138-2.
Macchia I, La Sorsa V, Ciervo A, Ruspantini I, Negri D, Borghi M Biomolecules. 2024; 14(10).
PMID: 39456150 PMC: 11505848. DOI: 10.3390/biom14101217.
Chen J, Han Z, Wang Z, Chen L, Wang S, Yao W BMC Psychiatry. 2024; 24(1):728.
PMID: 39448971 PMC: 11515564. DOI: 10.1186/s12888-024-06148-6.
Vaillancourt M, Aguilar D, Fernandes S, Jorth P bioRxiv. 2024; .
PMID: 39416002 PMC: 11482824. DOI: 10.1101/2024.10.07.617039.
IL-33 promotes double negative T cell survival via the NF-κB pathway.
Sun X, Zhang C, Sun F, Li S, Wang Y, Wang T Cell Death Dis. 2023; 14(4):242.
PMID: 37019882 PMC: 10076344. DOI: 10.1038/s41419-023-05766-4.